Max Planck Institute for Polymer Research
Bioactive Hydrogels for Applications in Medicine and Health Care
Biomedical Applications of DNA-Based Hydrogels. Adv. Funct. Mater. 2020, 30, 1906253. https://doi.org/10.1002/adfm.201906253
2019, 31, 1805044. https://doi.org/10.1002/adma.201805044
4. M. Pieszka, A. M. Sobota, J. Gačanin, T. Weil, D. Y. W. Ng, Orthogonally Stimulated Assembly/Disassembly of Depsipeptides by Rational Chemical Design, ChemBioChem 2019, 20, 1376. https://doi.org/10.1002/cbic.201800781
2017, 6, 1700392. https://doi.org/10.1002/adhm.201700392
Dr. Jasmina Gačanin studied Biochemistry at Ulm University, Germany, where she received her Bachelor’s (2013) and Master’s (2015) degrees as a scholarship holder of the “Studienstiftung des Deutschen Volkes”. She acquired her first research experiences working on the synthesis and investigation of morphological and transduction-promoting effects of self-assembling oligopeptides (Bachelor’s Thesis) and on supramolecular protein/peptide conjugates for therapeutic delivery (Master’s Thesis).
She continued her work in the group of Prof. Dr. Tanja Weil at Ulm University for her dissertation which she completed with summa cum laude in 2020. Her doctoral research focused on multifunctional hybrid hydrogels for medicinal applications such as tissue engineering and drug delivery employing various biomolecules such as proteins, peptides, and DNA to develop biohybrid hydrogels. Motivated by her early fascination about protein chemistry and inspired by the complex interplay of molecules in Nature, she continued her studies exploring the combination of the stability of covalent bonds with the dynamic behavior introduced by supramolecular chemistry. Thereby, grafting protein-derived backbones with supramolecular gelators of either DNA or nanofiber-forming peptides achieved outstanding material properties, making these gels highly attractive injectable cell scaffolds for regenerative medicine.
Since 2020, Jasmina Gačanin has been working as a postdoctoral researcher in the group of Prof. Dr. Tanja Weil at MPI-P, Mainz, Germany, as project responsible at the MPI-P, within the framework of a 3-year industrial cooperation on the BMBF project "Next Generation Injectable, Adaptive Hydrogels" (InGel-NxG, https://promatleben.de/de/projekte/projekte-alphabetisch/ingel-nxg/). In this cooperative project (TETEC AG, NMI Natural and Medical Sciences Institute at the University of Tübingen, NMI Technologietransfer, HOT Screen; Hochschule Albstadt-Sigmaringen, and associated partners Boehringer Ingelheim Pharma and Vetter Pharma-Fertigung) a material platform is developed as novel treatment option for the local therapy of economically significant and individually burdensome conditions, such as inflammatory joint diseases. Therapeutic hydrogels based on human serum albumin (HSA) that can act as depot formulations for pharmaceutical molecules, with a local, controllable release featuring adjustable material properties, as well as simple and fast production are envisioned.
2011 Scholarship Studienstiftung des deutschen Volkes
2010 Karl-von-Frisch-Preis (VBiO - Verband Biologie, Biowissenschaften & Biomedizin in Deutschland, München)
2010 Scheffel-Preis (Literarische Gesellschaft, Karlsruhe)
2021 SUPRABIO CONFERENCE 2021| Best Oral Communication: For the paper entitled "Supramolecular crosslinking: Advanced hydrogels for tissue engineering"
2020 Top 10% most downloaded papers 2018 - 2019: Advanced Materials; Gačanin et al., "Autonomous Ultra-Fast Self-Healing Hydrogels by pH-Responsive Functional Nanofiber Gelators as Cell Matrices"
2020 Top 10% most downloaded papers 2018 - 2019: Advanced Functional Materials; Gačanin et al., "Biomedical Applications of DNA-Based Hydrogels"
2020 Poster award #3 - Online Ceremony for 100 years polymer science and twitter poster session (GDCh)